• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Roles of chymase in the development of cardiac remodeling during heart failure progression.

Research Project

Project/Area Number 15590240
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field General pharmacology
Research InstitutionOsaka Medical College

Principal Investigator

JIN Denan  Osaka Medical College, Faculty of Medicine, Assistant Professor, 医学部, 講師 (90319533)

Co-Investigator(Kenkyū-buntansha) TAKAI Shinji  Osaka Medical College, Faculty of Medicine, Associate Professor, 医学部, 助教授 (80288703)
MURAMATSU Michiko  Osaka Medical College, Faculty of Medicine, Research Associate, 医学部, 助手 (30330096)
Project Period (FY) 2003 – 2004
Project Status Completed (Fiscal Year 2004)
Budget Amount *help
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 2004: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2003: ¥2,300,000 (Direct Cost: ¥2,300,000)
Keywordschymase / angiotensrn II / TGF-β1 / cardiac fibrosis / hepatic fibrosis / 心不全 / 精製 / 心筋症 / シャント
Research Abstract

It is well known that the mast cell derived chymase plays an important role in the generation of angiotensin (Ang) II form Ang II. In addition to its Ang II generation property, the recent studies confirmed that chymase also participate in the cleavage of latent transforming growth factor-beta 1 (TGF-ss1) to the active forms. Taking together, these results indicating that chymae may act as a fibrogenic facilitating factor to promote various organs remodeling during pathological conditions. To verify our this hypothesis, we have purified chymase from dog tongue, and injected it into the rat liver. In comparison with saline injection, the fibrotic area was significantly large after injection of the purified dog chymase and the fibrotic area was almost reduced to the saline injected level when the chymase was heated at 100 ℃ for 5 minutes. Interestingly, we found that the fibrogenic effect of chymase injection was concentration- and time-dependent. These findings direct demonstrated that … More the increase of chymase indeed accelerating fibrogenic processes, although it was unclear which pathway will be more important during these processes between Ang II-generating property and latent TGF-aa1 activation after injection of the chymase. To further confirm this issue, the effects of a chymase inhibitor and an Ang II receptor antagonist as well as a chymase inhibitor combined with an Ang II receptor antagonist are ongoing in the same model.
The roles of chymase during the development of cardiac hypertrophy and cardiomyopathy were also determined in a hamster model of abdominal arteriovenous (AV) fistula and by employing spontaneous cardiomyopathy hamsters. In these models, our immunohistochemical studies reviewed that the great deposition of chymase positive mast cells always accompanied the significant focal fibrotic legion, and the enzymetic activities of chymase in the disordered hearts were also increased significantly when these compared to the age-matched control normal heats. The effects of chymase inhibition and Ang II blockade as well as their combination to be pronounced in the near future. Less

Report

(3 results)
  • 2004 Annual Research Report   Final Research Report Summary
  • 2003 Annual Research Report
  • Research Products

    (30 results)

All 2005 2004 2003 Other

All Journal Article (23 results) Publications (7 results)

  • [Journal Article] The role of chymase in vascular remodeling and tissue fibrosis2005

    • Author(s)
      Takai S
    • Journal Title

      Curr Hypertens Rev (in press)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] The effect of chymase inhibition on the arteriovenous fistula stenosis in dogs2005

    • Author(s)
      Jin D
    • Journal Title

      J Am Soc Nephrol 16

      Pages: 1024-1034

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Effect of Chymase Inhibition on the Arteriovenous Fistula Stenosis in Dogs.2005

    • Author(s)
      Jin D
    • Journal Title

      J Am Soc Nephrol. (in press)

    • Related Report
      2004 Annual Research Report
  • [Journal Article] An antiarrhythmic effect of a chymase inhibitor after myocardial infarction2004

    • Author(s)
      Jin D
    • Journal Title

      J Pharmacol Exp Ther 309

      Pages: 490-497

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Significant target organs for hypertension and cardiac hypertrophy by angiotensin-converting enzyme inhibitors2004

    • Author(s)
      Takai S
    • Journal Title

      Hypertens Res 27

      Pages: 213-219

    • NAID

      10012844010

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] A specific chymase inhibitor, 2-(5-formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[{3,4-dioxo-1-phenyl-7-(2-pyridyloxy)}-2-heptyl}] acetamide (NK3201), suppresses development of abdominal aortic aneurysm in hamsters.2004

    • Author(s)
      Tsunemi K
    • Journal Title

      J Pharmacol Exp Ther 309

      Pages: 879-883

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] A single treatment with a specific chymase inhibitor, TY-51184, prevents vascular proliferation in canine grafted veins2004

    • Author(s)
      Takai S
    • Journal Title

      J Pharmacol Sci 94

      Pages: 443-448

    • NAID

      10012892021

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Comparative effects of candesartan and amlodipine in a monkey atherosclerotic model2004

    • Author(s)
      Takai S
    • Journal Title

      Hypertens Res 27

      Pages: 517-522

    • NAID

      10013515786

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] A specific chymase inhibitor, NK3201, suppresses bleomycin-induced pulmonary fibrosis in hamsters2004

    • Author(s)
      Sakaguchi M
    • Journal Title

      Eur J Pharmacol 493

      Pages: 173-176

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Letter to Editor : Human chymase degrades human fibronectin2004

    • Author(s)
      Okumura K
    • Journal Title

      Clin Chim Acta 347

      Pages: 223-225

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Chymase as a novel target for prevention of vascular diseases2004

    • Author(s)
      Takai S
    • Journal Title

      Trends Pharmacol Sci 25

      Pages: 518-522

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Therapeutic applications of chymase inhibitors in cardiovascular disease and fibrosis2004

    • Author(s)
      Takai S
    • Journal Title

      Eur J Pharmacol 501

      Pages: 1-8

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] An antiarrhythmic effect of a chymase inhibitor after myocardial infarction2004

    • Author(s)
      Jin D
    • Journal Title

      J Phamacol Exp Ther 909

      Pages: 490-497

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] A specific chymase inhibitor, 2-(5-formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[{3,4-dioxo-1-phenyl-7-(2-pyridyloxy)}-2-heptyl] acetamide(NK3201), suppresses development of abdominal aortic aneurysm in hamsters2004

    • Author(s)
      Tsunemi K
    • Journal Title

      J Pharmacol Exp Ther 309

      Pages: 879-883

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Therapeutic applications of chymase inhibitors in cardiovascular disease and fibrosis2004

    • Author(s)
      Takai S
    • Journal Title

      Fur J Phamacol 501

      Pages: 1-8

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Therapeutic applications of chymase inhibitors in cardiovascular diseases and fibrosis.2004

    • Author(s)
      Takai S
    • Journal Title

      Eur J Pharmacol. 501

      Pages: 1-8

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Chymase as a novel target for the prevention of vascular diseases.2004

    • Author(s)
      Takai S
    • Journal Title

      Trends Pharmacol Sci. 25

      Pages: 518-522

    • Related Report
      2004 Annual Research Report
  • [Journal Article] A specific chymase inhibitor, NK3201, suppresses bleomycin-induced pulmonary fibrosis in hamsters.2004

    • Author(s)
      Sakaguchi M
    • Journal Title

      Eur J Pharmacol. 493

      Pages: 173-176

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Significant target organs for hypertension and cardiac hypertrophy by angiotensin-converting enzyme inhibitors.2004

    • Author(s)
      Takai S
    • Journal Title

      Hypertens Res. 27

      Pages: 213-219

    • NAID

      10012844010

    • Related Report
      2004 Annual Research Report
  • [Journal Article] An antiarrhythmic effect of a chymase inhibitor after myocardial infarction.2004

    • Author(s)
      Jin D
    • Journal Title

      J Pharmacol Exp Ther. 309

      Pages: 490-497

    • Related Report
      2004 Annual Research Report
  • [Journal Article] Impact of chymase inhibitor on cardiac function and survival after myocardial infarction2003

    • Author(s)
      Jin D
    • Journal Title

      Cardiovasc Res 60

      Pages: 417-420

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells2003

    • Author(s)
      Fujiyama S
    • Journal Title

      Cir Res 93

      Pages: 980-989

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] A single treatment with a specific chymase inhibitor, TY-51184, prevents vascular proliferation in canin grafted veins2003

    • Author(s)
      Takai S
    • Journal Title

      J Pharmacol Sci 94

      Pages: 443-448

    • NAID

      10012892021

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Publications] Jin D: "An antiarrhysmic effect of a chymase inhibitor after myocardial infarction"J Pharmacol Exp Ther. in press. (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Takai S: "Significant target organs for hypertension and cardiac hypertrophy by angiotensin-converting enzyme inhibitors"Hypertens Res. in press. (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Tsunemi K: "A specific chymase inhibitor, 2-(5-formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[{3,4-dioxo-1-phenyl-7-(2-pyridyloxy)}-2-heptyl]acetamide (NK3201), suppresses development of abdominal aortic aneurysm in hamsters."J Pharmacol Exp Ther. in press. (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Jin D: "Impact of chymase inhibitor on cardiac function and survival after myocardial in farction"Cardiovasc Res. 60. 413-420 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Takai S: "A novel chymase inhibitor, 2-(5-Formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[{3,4-dioxo-1-phenyl-7-(2-pyridyloxy)}-2-heptyl]acetamide (NK3201), suppressed intimal hyperplasia after balloon Injury"J Pharmacol Exp Ther. 304. 841-844 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Fujiyama S: "Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells"Circulation Research. 93. 980-989 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Takai S: "A novel chymase inhibitor, BCEAB (4-[1-{[bis-(4-methyl-phenyl)-methyl]-carbamoyl}-3-(2-ethoxy-benzyl)-4-oxo-azetidine-2-yloxy]-benzoic acid) suppressed cardiac fibrosis in cardiomyopathic hamsters"J Pharmacol Exp Ther. 305. 17-23 (2003)

    • Related Report
      2003 Annual Research Report

URL: 

Published: 2003-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi